Does IPILIMUMAB Cause Intentional product use issue? 1,329 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,329 reports of Intentional product use issue have been filed in association with IPILIMUMAB (YERVOY). This represents 3.6% of all adverse event reports for IPILIMUMAB.
1,329
Reports of Intentional product use issue with IPILIMUMAB
3.6%
of all IPILIMUMAB reports
563
Deaths
347
Hospitalizations
How Dangerous Is Intentional product use issue From IPILIMUMAB?
Of the 1,329 reports, 563 (42.4%) resulted in death, 347 (26.1%) required hospitalization, and 70 (5.3%) were considered life-threatening.
Is Intentional product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IPILIMUMAB. However, 1,329 reports have been filed with the FAERS database.
What Other Side Effects Does IPILIMUMAB Cause?
Death (3,710)
Malignant neoplasm progression (3,296)
Diarrhoea (2,557)
Off label use (2,097)
Colitis (1,988)
Pyrexia (1,796)
Rash (1,556)
Fatigue (1,447)
Nausea (1,169)
Decreased appetite (990)
What Other Drugs Cause Intentional product use issue?
INFLIXIMAB (11,028)
RITUXIMAB (9,602)
INFLIXIMAB-DYYB (7,549)
TOCILIZUMAB (5,078)
METHOTREXATE (4,087)
PREDNISONE (3,961)
ABATACEPT (3,693)
ADALIMUMAB (3,557)
NIVOLUMAB (3,297)
LEFLUNOMIDE (3,280)
Which IPILIMUMAB Alternatives Have Lower Intentional product use issue Risk?
IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE
IPILIMUMAB vs IPRATROPIUM
IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS
IPILIMUMAB vs IPTACOPAN
IPILIMUMAB vs IRBESARTAN